Consistent with the results in AD patients, an increasing level of phosphorylated ERK1/2 was found in the 2,4-dinitrochlorobenzene (DNCB)-induced mouse model (Choi et al., 2021). This evidence concerns the gene MAPK3 and Alzheimer disease.